Company Overview
QUINCE THERAPEUTICS, INC.
QNCXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2024 FY
Net Income
-57M
2024 FY
Shares Outstanding
43M
2024 FY
EPS
-1.31USD
2024 FY
Company Information
SIC Code
2836
CIK Code
1662774
Exchange
Nasdaq
Location
US